Which statement correctly distinguishes affinity from avidity?

Which statement correctly distinguishes affinity from avidity?

• A. Avidity is the overall strength of multiple bindings; affinity is the strength of a single binding.
• B. Affinity is the overall strength of multiple bindings; avidity is the strength of a single binding.
• C. Both are identical concepts.
• D. Avidity only applies to IgM.

Answer: (A)

Affinity is the strength of a single antigen–antibody interaction at one binding site. Avidity, on the other hand, is the overall binding strength when multiple interactions occur simultaneously—for example, when an antibody with two or more binding sites engages a multivalent antigen or when receptors and ligands have several contact points. This means that even if each individual interaction is modest in strength, the combined multiple bonds can hold the complex together much more securely and for a longer time due to cooperative effects and slower dissociation. Avidity can be high with antibodies that have multiple binding sites, like IgG with two Fab arms or IgM with many binding sites, and it depends on factors such as valency, epitope density, and the spatial arrangement of binding sites. Affinity is quantified for a single binding event, often described by a dissociation constant (Kd), while avidity reflects the functional outcome of multiple interactions in a real, multivalent context. So the correct statement is that avidity describes the overall strength of multiple bindings, whereas affinity describes the strength of a single binding event. The idea that affinity is the overall strength, or that both terms are identical, or that avidity is exclusive to IgM, does not fit the true distinction between these concepts.

Affinity is the strength of a single antigen–antibody interaction at one binding site. Avidity, on the other hand, is the overall binding strength when multiple interactions occur simultaneously—for example, when an antibody with two or more binding sites engages a multivalent antigen or when receptors and ligands have several contact points. This means that even if each individual interaction is modest in strength, the combined multiple bonds can hold the complex together much more securely and for a longer time due to cooperative effects and slower dissociation.

Avidity can be high with antibodies that have multiple binding sites, like IgG with two Fab arms or IgM with many binding sites, and it depends on factors such as valency, epitope density, and the spatial arrangement of binding sites. Affinity is quantified for a single binding event, often described by a dissociation constant (Kd), while avidity reflects the functional outcome of multiple interactions in a real, multivalent context.

So the correct statement is that avidity describes the overall strength of multiple bindings, whereas affinity describes the strength of a single binding event. The idea that affinity is the overall strength, or that both terms are identical, or that avidity is exclusive to IgM, does not fit the true distinction between these concepts.